RAPT Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RAPT Nasdaq 2836 www.rapt.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for RAPT Therapeutics, Inc.

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors - Jun 23rd, 2025 6:00 am
Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know - Jun 18th, 2025 7:55 am
Rapt Therapeutics announces effective date for 1-for-8 reverse stock split - Jun 14th, 2025 7:05 am
RAPT Therapeutics to Participate in Upcoming Investor Conferences - Jun 4th, 2025 2:05 pm
Rapt Therapeutics (RAPT) Upgraded to Buy: Here's What You Should Know - May 16th, 2025 10:00 am
RAPT Therapeutics Reports First Quarter 2025 Financial Results - May 8th, 2025 6:00 am
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development - Apr 15th, 2025 6:00 am
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 6th, 2025 6:00 am
Hanmi Pharmaceuticals reports data from trial of Tivumecirnon for gastric cancer - Feb 18th, 2025 4:29 am
All You Need to Know About Rapt Therapeutics (RAPT) Rating Upgrade to Buy - Feb 10th, 2025 10:00 am
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 9th, 2025 6:00 am
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors - Jan 6th, 2025 6:00 am
Rapt Therapeutics upgraded to Buy from Neutral at H.C. Wainwright - Dec 27th, 2024 4:10 am
Progressive, EverQuote upgraded: Wall Street's top analyst calls - Dec 26th, 2024 7:35 am
RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement - Dec 24th, 2024 4:44 am
Why RAPT Therapeutics Stock Gained Over 100% On Monday? - Dec 23rd, 2024 11:00 am
RAPT Therapeutics Announces $150 Million Private Placement - Dec 23rd, 2024 5:10 am
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody - Dec 23rd, 2024 5:00 am
RAPT Therapeutics Reports Third Quarter 2024 Financial Results - Nov 12th, 2024 6:00 am
RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull - Nov 11th, 2024 10:18 am